MD, Linköping University (1989), Specialist in Neurology (1993), Specialist in Clinical Chemistry (1999), PhD, Linköping University (1999), Associate professor, Linköping University (2012), Sweden
Since 2002, member of the Steering Board of the Swedish Movement Disorder Society, SWEMODIS, affiliated to the International Parkinson and Movement Disorder Society, MDS. Founding member of the Scandinavian Movement Disorder Society, Scandmodis. Since 2009, she is also member (and founding member) of the steering board of the Swedish National Network for Parkinson Research, SWEPAR-Net
Experience and prior assignments
More than 25 years of experience from Neurology. She is also specialist in Clinical Chemistry and started her research on Malignant melanoma and later on Parkinson’s disease. The knowledge from both these fields led to the development of the first Infudopa™ formulation for intravenous use. She is one of the founders of Dizlin Pharmaceuticals AB.